Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.
Galløe AM, Thuesen L, Kelbaek H, Thayssen P, Rasmussen K, Hansen PR, Bligaard N, Saunamäki K, Junker A, Aarøe J, Abildgaard U, Ravkilde J, Engstrøm T, Jensen JS, Andersen HR, Bøtker HE, Galatius S, Kristensen SD, Madsen JK, Krusell LR, Abildstrøm SZ, Stephansen GB, Lassen JF; SORT OUT II Investigators. Galløe AM, et al. Among authors: abildgaard u. JAMA. 2008 Jan 30;299(4):409-16. doi: 10.1001/jama.299.4.409. JAMA. 2008. PMID: 18230778 Clinical Trial.
Field triage reduces treatment delay and improves long-term clinical outcome in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Pedersen SH, Galatius S, Hansen PR, Mogelvang R, Abildstrom SZ, Sørensen R, Davidsen U, Galloe A, Abildgaard U, Iversen A, Bech J, Madsen JK, Jensen JS. Pedersen SH, et al. Among authors: abildgaard u. J Am Coll Cardiol. 2009 Dec 8;54(24):2296-302. doi: 10.1016/j.jacc.2009.06.056. J Am Coll Cardiol. 2009. PMID: 19958965 Free article.
Long-term prognosis in an ST-segment elevation myocardial infarction population treated with routine primary percutaneous coronary intervention: from clinical trial to real-life experience.
Pedersen S, Galatius S, Mogelvang R, Davidsen U, Galloe A, Abildstrom SZ, Abildgaard U, Hansen PR, Bech J, Iversen A, Jorgensen E, Kelbaek H, Saunamaki K, Madsen JK, Jensen JS. Pedersen S, et al. Among authors: abildgaard u. Circ Cardiovasc Interv. 2009 Oct;2(5):392-400. doi: 10.1161/CIRCINTERVENTIONS.108.845636. Epub 2009 Aug 18. Circ Cardiovasc Interv. 2009. PMID: 20031748
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.
Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, Abildgaard U, Christiansen EH, Engstrøm T, Krusell LR, Ravkilde J, Hansen PR, Hansen KN, Abildstrøm SZ, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Madsen M, Johnsen SP, Jensen LO, Sørensen HT, Thuesen L, Lassen JF; SORT OUT III study group. Rasmussen K, et al. Among authors: abildgaard u. Lancet. 2010 Mar 27;375(9720):1090-9. doi: 10.1016/S0140-6736(10)60208-5. Epub 2010 Mar 16. Lancet. 2010. PMID: 20231034 Clinical Trial.
Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial.
Iversen A, Abildgaard U, Galloe A, Hansen PR, Galatius S, Madsen JK, Engstroem T, Pedersen S, Jensen KS, Jensen JS. Iversen A, et al. Among authors: abildgaard u. J Interv Cardiol. 2011 Apr;24(2):105-11. doi: 10.1111/j.1540-8183.2010.00616.x. Epub 2010 Dec 22. J Interv Cardiol. 2011. PMID: 21175845 Free article. Clinical Trial.
Long-term clinical outcome in STEMI patients treated with primary PCI and drug-eluting or bare-metal stents: insights from a high-volume single-center registry.
Pedersen S, Galatius S, Mogelvang R, Abildstrom SZ, Sorensen R, Galloe A, Abildgaard U, Hansen P, Davidsen U, Iversen A, Bech J, Madsen JK, Jensen JS. Pedersen S, et al. Among authors: abildgaard u. J Invasive Cardiol. 2011 Aug;23(8):328-33. J Invasive Cardiol. 2011. PMID: 21828395 Free article.
Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy).
Maeng M, Jensen LO, Tilsted HH, Kaltoft A, Kelbaek H, Abildgaard U, Villadsen A, Aarøe J, Thayssen P, Krusell LR, Christiansen EH, Bøtker HE, Kristensen SD, Ravkilde J, Madsen M, Sørensen HT, Rasmussen K, Thuesen L, Lassen JF. Maeng M, et al. Among authors: abildgaard u. Am J Cardiol. 2011 Nov 1;108(9):1232-7. doi: 10.1016/j.amjcard.2011.06.037. Epub 2011 Aug 23. Am J Cardiol. 2011. PMID: 21864817 Clinical Trial.
3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents.
Maeng M, Tilsted HH, Jensen LO, Kaltoft A, Kelbæk H, Abildgaard U, Villadsen AB, Krusell LR, Ravkilde J, Hansen KN, Christiansen EH, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Madsen M, Thayssen P, Sørensen HT, Thuesen L, Lassen JF. Maeng M, et al. Among authors: abildgaard u. JACC Cardiovasc Interv. 2012 Aug;5(8):812-8. doi: 10.1016/j.jcin.2012.04.008. JACC Cardiovasc Interv. 2012. PMID: 22917452 Free article. Clinical Trial.
Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study.
Kristensen SL, Galløe AM, Thuesen L, Kelbæk H, Thayssen P, Havndrup O, Hansen PR, Bligaard N, Saunamäki K, Junker A, Aarøe J, Abildgaard U, Jeppesen JL. Kristensen SL, et al. Among authors: abildgaard u. PLoS One. 2014 Nov 19;9(11):e113399. doi: 10.1371/journal.pone.0113399. eCollection 2014. PLoS One. 2014. PMID: 25409336 Free PMC article.
278 results